Search

Search Constraints

You searched for: Author/Creator Nassif, Michael E.

Search Results

3. Association Between Change in Ambulatory Hemodynamic Pressures and Symptoms of Heart Failure. (November 2021)

4. Association between sacubitril/valsartan initiation and real‐world health status trajectories over 18 months in heart failure with reduced ejection fraction. (1st May 2021)

5. Cardiometabolic Center of Excellence: A Novel Care Delivery Model for Secondary Prevention of Cardiovascular Disease in Type 2 Diabetes. Issue 10 (30th September 2021)

7. Dapagliflozin effects on lung fluid volumes in patients with heart failure and reduced ejection fraction: Results from the DEFINE‐HF trial. Issue 6 (26th March 2021)

8. Effects of Empagliflozin on Symptoms, Physical Limitations, and Quality of Life in Patients Hospitalized for Acute Heart Failure: Results From the EMPULSE Trial. Issue 4 (4th April 2022)

10. Empagliflozin Effects on Pulmonary Artery Pressure in Patients With Heart Failure: Results From the EMBRACE-HF Trial. Issue 17 (27th April 2021)